ADVERTISEMENTs

Indian-American named chair of neurology at Stony Brook University

Verghese's appointment was made by Dr. Peter Igarashi, Knapp dean of the RSOM, who emphasized the importance of his expertise in addressing age-related illnesses. 

Joe Verghese / Image- Courtesy of Joe Verghese

Indian American physician, researcher, and educator, Dr. Joe Verghese has been appointed chair of the Department of Neurology at the Renaissance School of Medicine (RSOM) at Stony Brook University effective Oct. 14.

A recognized expert in gait and cognitive aging, Verghese has over two decades of experience at the Albert Einstein College of Medicine, where he served as Professor of Neurology and Medicine and was the inaugural chief of the Division of Cognitive and Motor Aging in the Department of Neurology.

Verghese's appointment was made by Dr. Peter Igarashi, Knapp dean of the RSOM, who emphasized the importance of his expertise in addressing age-related illnesses. 

“Our aging society has a great need for medical experts who will advance preventive and treatment strategies for age-related illnesses, and the selection of Dr. Verghese as our new Neurology chair ensures that this area of medicine will thrive within the Renaissance School of Medicine,” said Igarashi.

Verghese’s work has focused on dementia, gait disorders, and frailty, with his contributions to research helping to define Motoric Cognitive Risk Syndrome, a pre-dementia syndrome.

Speaking of his priorities, Verghese said, “My primary goal as chair is to cultivate a collaborative environment that not only fosters innovative research and comprehensive patient care but also prioritizes education.”

Verghese is a graduate of St. John’s Medical College in Bangalore, India, and completed his postgraduate training in the United Kingdom before completing his residency and fellowship in Neurology and Aging and Dementia at Albert Einstein College of Medicine. His research has been continually funded by the National Institutes of Health (NIH) since 2002, with over US$ 200 million in research funding to date.

Additionally, his work in cognitive aging has earned him numerous accolades, including the Beeson Award from the National Institute on Aging and the Joseph T. Freeman Award from the Gerontological Society of America.
 

Comments

ADVERTISEMENT

 

 

 

ADVERTISEMENT

 

 

E Paper

 

 

 

Video